Human IFNE (IFNE1) knockout HeLa cell lysate
Be the first to review this product! Submit a review
|
(0 Publication)
IFNE KO cell lysate available now. KO validated by. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon1 and 28 bp deletion in exon1.
View Alternative Names
Antiluteolysin, IFN-epsilon, IFNE1, IFNE_HUMAN, IFNT1, Interferon epsilon, Interferon epsilon-1, Interferon tau 1, PRO655, TP1, Trophoblastin
- Sanger seq
Unknown
Sanger Sequencing - Human IFNE (IFNE1) knockout HeLa cell lysate (AB263235)
Allele-2 : 28 bp deletion in exon1
- Sanger seq
Unknown
Sanger Sequencing - Human IFNE (IFNE1) knockout HeLa cell lysate (AB263235)
Allele-1 : 1 bp insertion in exon1
Product details
Knockout cell lysate achieved by CRISPR/Cas9.
REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.
Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.
User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.
This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.
What's included?
Properties and storage information
Gene name
Gene editing type
Gene editing method
Knockout validation
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
IFNE contributes to the innate immune system by modulating immune responses without being part of a larger protein complex. It activates signaling pathways that result in the production of other immune response mediators. This protein supports the barrier function of epithelial cells enhancing the organism's ability to fend off infectious agents. Additionally it helps maintain homeostatic conditions in mucosal tissues by managing inflammation.
Pathways
IFNE integrates into the broader interferon signaling pathway and the JAK-STAT signaling pathway. These pathways mediate various cellular responses to external stimuli including pathogen infections. IFNE interacts with sister proteins such as IFN-alpha and IFN-beta in these pathways to drive protective responses and regulate inflammation. Understanding its pathway involvement assists researchers in designing targeted therapies for immune modulation.
Quality control
STR analysis
D7S820, D5S818, TH01, D16S539, TPOX, CSF1PO, D13S317
Cell culture
Biosafety level
EU: 2 US: 2
Adherent/suspension
Adherent
Gender
Female
Complementary Products
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com